. Author manuscript; available in PMC: 2021 Jul 1.

Published in final edited form as: Photodermatol Photoimmunol Photomed. 2020 Oct 4;37(1):34–38. doi: 10.1111/phpp.12604

Table 3. Response in NB-UVB treated conditions. N=86.

Diagnosis	N(%)	Mean number of treatment (range)	MCD J/cm2 (range)	Response(%)
Diagnosis	N(%)	Mean number of treatment (range)	MCD J/cm2 (range)	Clear/almost clear	Significant	Moderate	Minimal	No better/worse
Psoriasis	65(75.5)	20(1-36)	32.1 (0.28-160.47)	37(56.9)	18(27.7)	1(1.5)	4(6.2)	5(7.7)
Atopic Eczema	10(11.6)	21(1-40)	26.52 (0.07-113.93)	2 (20)	4(40)	0	0	4(40)
Vitiligo	8(9.3)	49(14-131)	24.84 (1.32-47.86)	0	3(37.5)	0	2(25)	3(37.5)
HV	1(1.2)	21	13.38	-	1(100)	-	-	-
PLC	2(2.3)	23(17-29)	42.16 (29.94-54.37)	-	2(100)	-	-	-

N, number; MCD, mean cumulative dose; HV, Hyroa Vacciniforme; PLE, Polymorphic light eruption; PLC, Pityriasis lichenoides chronica.